Yuanlong Pan

Dr. Yuanlong Pan

Nestle Research Center-St Louis, 1 Checkerboard Square, 2RS, St Louis, MO 63164, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2018 in Microbiome
Verified
Journal Article
Open access
PDF file
LCLuis Pedro Coelho
Luis Pedro Coelho
JKJens Roat Kultima
Jens Roat Kultima
PCPaul Igor Costea
Paul Igor Costea
CFCoralie Fournier
Coralie Fournier
YPYuanlong Pan
Yuanlong Pan
PBPeer Bork
Peer Bork
Gut microbes influence their hosts in many ways, in particular by modulating the impact of diet. These effects have been studied most extensively in humans and mice. In this work, we used whole genome metagenomics to investigate the relationship between the gut metagenomes of dogs, humans, mice, and pigs. We present a dog gut microbiome gene catalog containing 1,247,405 genes (based on 129 metagenomes and a total of 1.9 terabasepairs of sequencing data). Based on this catalog and taxonomic abundance profiling, we show that the dog microbiome is closer to the human microbiome than the microbiome of either pigs or mice. To investigate this similarity in terms of response to dietary changes, we report on a randomized intervention with two diets (high-protein/low-carbohydrate vs. lower protein/higher carbohydrate). We show that diet has a large and reproducible effect on the dog microbiome, independent of breed or sex. Moreover, the responses were in agreement with those observed in previous human studies. We conclude that findings in dogs may be predictive of human microbiome results. In particular, a novel finding is that overweight or obese dogs experience larger compositional shifts than lean dogs in response to a high-protein diet.

12 December 2018 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YPYuanlong Pan
Yuanlong Pan
GLGary Landsberg
Gary Landsberg
IMIsabelle Mougeot
Isabelle Mougeot
SKStephanie Kelly
Stephanie Kelly
HXHui Xu
Hui Xu
NMNorton W. Milgram
Norton W. Milgram
Cognitive dysfunction syndrome (CDS) is a common condition in senior dogs, which may be analogous to dementia such as Alzheimer's disease (AD) in people. In humans, AD has been associated with many risk factors such as reduced cerebral glucose metabolism, docosahexaenoic acid (DHA) deficiency, chronic oxidative stress, and chronic inflammation. By targeting some of these risk factors, we have developed two nutritional solutions (medium chain triglyceride, MCT and Brain Protection Blend, BPB) to enhance cognitive function and slow aging-induced cognitive decline. These have been positively evaluated in colony housed senior dogs and cats. The objective of this clinical study was to evaluate the effects of diets with MCTs and the BPB on client-owned dogs with CDS. Participating veterinary clinics screened senior dogs for signs of CDS as determined by a Senior Canine Behavior Questionnaire and a Canine Medical Health Questionnaire. Eighty-seven dogs were randomly enrolled into one of three diet groups with 29 dogs per group: Control, 6.5% MCT oil + BPB (6.5% MCT diet), 9% MCT oil + BPB (9% MCT diet). Diets were fed for a period of 90 days, and each dog's CDS signs were re-evaluated at day 30 and day 90. All 6 categories of the CDS signs were significantly improved (p <0.05) in the dogs given the 6.5% MCT diet at the end of the 90-day study. Control only improved in 4 out 6 categories. The 9% MCT diet only improved in dogs that accepted the diet. The results from this dog study confirm the benefits of MCT and BPB in managing clinical signs of CDS in dogs. The results support our hypothesis that targeting known risk factors associated with brain aging and AD is able to improve symptoms of CDS in dogs. These data may facilitate the development of similar nutrient blends to manage MCI and AD.

5 December 2012 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
YPYuanlong Pan
Yuanlong Pan
JAJoseph A. Araujo
Joseph A. Araujo
JBJoey Burrows
Joey Burrows
CRChristina de Rivera
Christina de Rivera
AGAsa Gore
Asa Gore
NMNorton W. Milgram
Norton W. Milgram
Cognitive dysfunction syndrome is a major disease affecting old cats and is the consequence of severe and irreversible loss of brain cells and brain atrophy. The present study focused on the hypothesis that the optimal strategy for promoting successful brain ageing is to target risk factors associated with brain ageing and dementia. We used a nutritional strategy involving supplementation with a blend of nutrients (antioxidants, arginine, B vitamins and fish oil) to test this hypothesis. Middle-aged and old cats between 5·5 and 8·7 years of age were assigned to cognitively equivalent control or treatment groups based on prior cognitive experience and performance on baseline cognitive tests. The cats in the treatment group were maintained on a diet supplemented with the nutrient blend and the cats in the control group were maintained on the identical base diet without the additional supplementation. After an initial wash-in period, all cats were tested on a battery of cognitive test protocols. The cats fed the test diet showed significantly better performance on three of four test protocols: a protocol assessing egocentric learning, a protocol assessing discrimination and reversal learning and a protocol focused on acquisition of a spatial memory task. The results support the hypothesis that brain function of middle-aged and old cats can be improved by the nutrient blend that was selected to minimise or eliminate the risk factors associated with brain ageing and dementia.

10 January 2018 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
YPYuanlong Pan
Yuanlong Pan
AKAdam D. Kennedy
Adam D. Kennedy
TJThomas J. Jönsson
Thomas J. Jönsson
NMNortan W. Milgram
Nortan W. Milgram
This study focused on the hypothesis that cognitive decline in aged dogs could be attenuated by dietary supplementation with a nutrient blend consisting of antioxidants, B vitamins, fish oil andl-arginine, referred to hereafter as the Brain Protection Blend (BPB). Baseline cognitive assessment before the start of treatment was used to establish cognitively equivalent control (10·464+2·33 kg) and treatment (12·118+3·386 kg) groups of aged dogs between 9·1 and 11·5 years of age and with body condition score of 5. After an initial wash-in period, all dogs were tested over a 6-month period on cognitive test protocols that assessed four phases of a landmark discrimination learning protocol, which assessed a spatial learning skill based on utilisation of external cues, and egocentric discrimination task, which assessed spatial learning based on internal body-centred cues. The BPB-supplemented group showed significantly better performance than the controls on the landmark 1 (P=0·0446) discrimination learning tasks, and on two egocentric discrimination reversal learning tasks (P=0·005 andP=0·01, respectively). The groups did not differ significantly (P>0·10) on the landmark zero discrimination task and the egocentric discrimination learning task. These results suggest beneficial effects are positively linked to task complexity. Many of the nutrients supplemented in the BPB diet were significantly higher in plasma, including arginine,α-tocopherol, DHA and EPA. These results indicate that long-term supplementation with the BPB can have cognition-improving effects and support the use of nutritional strategies in targeting brain ageing-associated risk factors as an intervention to delay cognitive ageing.

18 November 2021 in Medical Sciences
Verified
Journal Article
Open access
PDF file
YPYuanlong Pan
Yuanlong Pan
Due to a difference in genetics, environmental factors, and nutrition, just like in people, dogs age at different rates. Brain aging in people and dogs share similar morphological changes including irreversible cortical atrophy, cerebral amyloid angiopathy, and ventricular enlargement. Due to severe and irreversible brain atrophy, some aging dogs develop cognitive dysfunction syndrome (CDS), which is equivalent to dementia or Alzheimer’s disease (AD) in people. The risk factors and causes of CDS in dogs have not been fully investigated, but age, gender, oxidative stress, and deficiency of sex hormones appears to be associated with increased risk of accelerated brain aging and CDS in dogs. Both AD and CDS are incurable diseases at this moment, therefore more efforts should be focused on preventing or reducing brain atrophy and minimizing the risk of AD in people and CDS in dogs. Since brain atrophy leads to irreversible cognitive decline and dementia, an optimal nutritional solution should be able to not only enhance cognitive function during aging but also reduce irreversible brain atrophy. Up to now, only one nutritional intervention has demonstrated both cognition-enhancing benefits and atrophy-reducing benefits.

4 June 2023 in Journal of Animal Science
Verified
Journal Article
Closed access
PDF file
YPYuanlong Pan
Yuanlong Pan
JSJulie K Spears
Julie K Spears
HXHui Xu
Hui Xu
SBSandeep Bhatnagar
Sandeep Bhatnagar
Obesity has become a major health issue in dogs. Obesity in dogs increases the risk of many chronic diseases and chronic low-grade inflammation. The objective of this study was to determine the effect of a therapeutic weight loss (TWL) diet on weight loss and metabolic health in overweight and obese dogs. Thirty overweight and obese dogs were randomized into two groups with 15 dogs per group based on key baseline parameters and allotted to either a control or TWL diet for 6 months. At the start of the study, the control group had 6 females and 9 males with mean age of 9.12 ± 0.48 (mean ± SEM) years; there were 7 females and 8 males with mean age of 9.73 ± 0.63 years in the TWL group. The control group and the TWL group had comparable body weight (34.78 ± 0.76 kg and 34.63 ± 0.86 kg, respectively), % body fat (39.77 ± 1.18 and 39.89 ± 0.93, respectively), and body condition score (BCS) (7.80 ± 0.14 and 7.67 ± 0.16 on a 9-point BCS scale, respectively). The control diet was formulated based on the macronutrient ratio of a commercial metabolic diet, and the TWL diet was enriched with dietary protein, fish oil, and soy germ meal. Both diets were fortified with essential nutrients to account for caloric restriction during weight loss. Dogs were fed 25% less than baseline maintenance energy requirement (MER) for the first 4 months and if they did not reach a body condition score (BCS) of 5, they were fed 40% less than baseline MER for the last 2 months. Body composition was determined by dual-energy x-ray absorptiometry. Postprandial glucose profiles were determined by continuous glucose monitoring devices. Serum samples were collected for analyses of blood parameters, hormones, and cytokines. All data were analyzed using SAS 9.3, with significance being P < 0.05. At the end of the study, the control group and the TWL group had comparable weight loss (-5.77 ± 0.31 kg and -6.14 ± 0.32 kg, respectively; P = 0.4080). But the TWL group lost significantly (P = 0.034) more body fat (-13.27 ± 1.28%) than the control group (-9.90 ± 1.23%). In addition, the TWL diet completely prevented loss of lean body mass (LBM) in dogs compared with baseline. Dogs fed the TWL diet had significantly lower fasting serum cholesterol, triglycerides, insulin, leptin, mean postprandial interstitial glucose, and pro-inflammatory cytokines compared with dogs fed the control diet. In summary, the TWL diet prevented loss of LBM, promoted weight loss and metabolic health, and reduced pro-inflammatory cytokines and chemokines in overweight and obese dogs during weight loss.